Adverse events85

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 85

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Arthralgia	Musculoskeletal and connective tissue disorders	Tofacitinib 11mg MR	3	102
other	Arthralgia	Musculoskeletal and connective tissue disorders	PF-06651600 100mg	5	77
other	Arthralgia	Musculoskeletal and connective tissue disorders	PF-06650833 400mg MR	1	77
other	Arthralgia	Musculoskeletal and connective tissue disorders	PF-06650833 400mg MR + Tofacitinib 11mg MR	2	103
other	Arthralgia	Musculoskeletal and connective tissue disorders	PF-06650833 400mg MR + PF-06651600 100mg	2	101
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	Tofacitinib 11mg MR	3	102
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	PF-06651600 100mg	4	77
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	PF-06650833 400mg MR	4	77
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	PF-06650833 400mg MR + Tofacitinib 11mg MR	1	103
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	PF-06650833 400mg MR + PF-06651600 100mg	1	101
other	Headache	Nervous system disorders	Tofacitinib 11mg MR	4	102
other	Headache	Nervous system disorders	PF-06651600 100mg	4	77
other	Headache	Nervous system disorders	PF-06650833 400mg MR	2	77
other	Headache	Nervous system disorders	PF-06650833 400mg MR + Tofacitinib 11mg MR	3	103
other	Headache	Nervous system disorders	PF-06650833 400mg MR + PF-06651600 100mg	7	101
serious	COVID-19 pneumonia	Infections and infestations	Tofacitinib 11mg MR	0	102
serious	COVID-19 pneumonia	Infections and infestations	PF-06651600 100mg	0	77
serious	COVID-19 pneumonia	Infections and infestations	PF-06650833 400mg MR	0	77
serious	COVID-19 pneumonia	Infections and infestations	PF-06650833 400mg MR + Tofacitinib 11mg MR	0	103
serious	COVID-19 pneumonia	Infections and infestations	PF-06650833 400mg MR + PF-06651600 100mg	1	101

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04413617/events?page=2

API reference For AI assistants